Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-23-006445

CHIEF ACCOUNTING OFFICER gave up 1,155 shares (to pay taxes)

  • CHIEF ACCOUNTING OFFICER acquired 3,933 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Megna Michael R CHIEF ACCOUNTING OFFICER 2023-04-10 Option exercise +3,933 14,132 D
Megna Michael R CHIEF ACCOUNTING OFFICER 2023-04-10 Shares withheld for taxes −1,155 $10.71 $12,370 12,977 D
Derivatives
Megna Michael R CHIEF ACCOUNTING OFFICER 2023-04-10 Option exercise · Restricted Share Unit +3,933 11,797 D
Loading xslF345X04/form4-04112023_090411.xml…